secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solana Co (HSDT)
CIK:        0001610853
Form:       8-K
Filed at:   2024-05-13T23:59:59+00:00
Accession:  0001558370-24-007961
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Helius Medical Q1 rev $135K (+22% YoY); net loss flat $2.5M; CMS PoNS reimbursement milestone
--------------------------------------------------------------------------------

- Q1 revenue $135K vs $111K YoY; operating loss $3.4M vs $3.8M, driven by lower professional fees and clinical trial costs.
- Net loss $2.5M (both periods); EPS -$3.08 vs -$4.42 in Q1 2023.
- Cash $3.6M at March 31; raised $5.6M net in May public offering, extending cash runway into 2025.
- Received CMS HCPCS preliminary reimbursement determination for PoNS; final price expected Oct 1, 2024.
- Added six sites to stroke registrational program; reached FDA alignment on stroke development plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610853/000155837024007961/0001558370-24-007961-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610853/000155837024007961/hsdt-20240513x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-007961

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer